-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Market analysis of chemical machinery and equipment network ] The biopharmaceutical industry is supported by favorable policies, and the development will continue to accelerate, bringing growth to domestic biopharmaceutical equipment , and there is a large space for import substitution
.
The prospects of the domestic pharmaceutical equipment industry are generally optimistic, but in the process of accelerating the transformation and upgrading of the industry, the industry concentration will continue to increase, and the market competition will become increasingly fierce
.
So, how should companies respond?
Chemical Machinery Equipment Network Market Analysis Chemical Machinery Equipment Pharmaceutical Equipment.
The prospects of the domestic pharmaceutical equipment industry are generally optimistic, but in the process of accelerating the transformation and upgrading of the industry, the industry concentration will continue to increase, and the market competition will become increasingly fierce
.
So, how should companies respond?
The domestic pharmaceutical equipment industry has broad prospects
The domestic pharmaceutical equipment industry has broad prospectsIn recent years, with the intensification of aging, the improvement of residents' living standards and the continuous enhancement of health awareness, their demand for drugs will continue to expand, bringing opportunities to the pharmaceutical equipment industry
.
At the same time, the promotion of policies such as consistency evaluation and normalization of centralized procurement has accelerated the reform of China's pharmaceutical industry.
As the "mother machine" of pharmaceutical production, the pharmaceutical equipment industry is facing a situation of transformation and upgrading, and investment in China's pharmaceutical manufacturing industry is increasing.
It will bring a new round of development opportunities for the pharmaceutical equipment industry
.
.
At the same time, the promotion of policies such as consistency evaluation and normalization of centralized procurement has accelerated the reform of China's pharmaceutical industry.
As the "mother machine" of pharmaceutical production, the pharmaceutical equipment industry is facing a situation of transformation and upgrading, and investment in China's pharmaceutical manufacturing industry is increasing.
It will bring a new round of development opportunities for the pharmaceutical equipment industry
.
Since 2020, the high-speed development of biotech and CDMO enterprise industries has also driven the growth of demand for biopharmaceutical equipment.
Due to factors such as delayed delivery of imported equipment, domestic equipment companies have received many orders
.
The industry believes that as the biopharmaceutical industry is supported by favorable policies and the development continues to accelerate, it will bring growth to domestic biopharmaceutical equipment, with large room for import substitution and broad long-term demand
.
In general, the prospects of the domestic pharmaceutical equipment industry are relatively broad
.
Due to factors such as delayed delivery of imported equipment, domestic equipment companies have received many orders
.
The industry believes that as the biopharmaceutical industry is supported by favorable policies and the development continues to accelerate, it will bring growth to domestic biopharmaceutical equipment, with large room for import substitution and broad long-term demand
.
In general, the prospects of the domestic pharmaceutical equipment industry are relatively broad
.
Market competition is becoming increasingly fierce, how should enterprises respond?
Market competition is becoming increasingly fierce, how should enterprises respond? Although the prospects of the domestic pharmaceutical equipment industry are generally optimistic, in the process of accelerating the transformation and upgrading of the industry, the industry concentration will continue to increase, and the market competition will become increasingly fierce
.
For many pharmaceutical machine companies, this means that they will face the risk of a decline in the profitability of their main business
.
So, how should companies respond?
.
For many pharmaceutical machine companies, this means that they will face the risk of a decline in the profitability of their main business
.
So, how should companies respond?
First, the layout of the international market will bring impetus to the growth of the enterprise
.
China's pharmaceutical equipment industry is changing from the extensive production mode in the past to a high-precision, high-quality stable development mode.
In this context, pharmaceutical machinery companies can meet the needs of the domestic market, and can also open up new international strategic layouts Profit growth point to cope with the increasingly fierce domestic competition
.
.
China's pharmaceutical equipment industry is changing from the extensive production mode in the past to a high-precision, high-quality stable development mode.
In this context, pharmaceutical machinery companies can meet the needs of the domestic market, and can also open up new international strategic layouts Profit growth point to cope with the increasingly fierce domestic competition
.
For example, Tofflon is committed to the systematic construction of various fields of the pharmaceutical equipment industry, actively explores new international markets, absorbs the technologies and advantages of international counterparts, and strengthens its international market share while consolidating its brand position in the domestic market
.
By the end of 2020, the company's international operating income accounted for about 20%; Chutian Technology has further accelerated its internationalization process through the acquisition of Germany's Romaco Group
.
In 2020, the company's foreign revenue increased by 6.
63% year-on-year
.
Among them, ROMACO company achieved a net profit of 73.
7226 million yuan for the year, exceeding the performance target with a completion rate of 133.
73%
.
The company stated that it will continue to promote the internationalization process of the company in the future, and plans to increase the share of overseas sales to 50% of the total revenue
.
.
By the end of 2020, the company's international operating income accounted for about 20%; Chutian Technology has further accelerated its internationalization process through the acquisition of Germany's Romaco Group
.
In 2020, the company's foreign revenue increased by 6.
63% year-on-year
.
Among them, ROMACO company achieved a net profit of 73.
7226 million yuan for the year, exceeding the performance target with a completion rate of 133.
73%
.
The company stated that it will continue to promote the internationalization process of the company in the future, and plans to increase the share of overseas sales to 50% of the total revenue
.
Second, improve the internal management level of enterprises
.
Under the background of rising raw material and labor costs year by year, intensified industry competition, high product overlap rate, and continuous price wars, the profit margins of pharmaceutical machine companies are constantly being squeezed, which poses challenges to the internal management level of the company
.
However, there are generally deficiencies and shortcomings in the operation and management of pharmaceutical machine enterprises in China.
How to improve technological innovation capabilities, how to reduce cost waste, how to promote strategic layout.
.
.
Every aspect requires enterprises to carry out "lean management"
.
.
Under the background of rising raw material and labor costs year by year, intensified industry competition, high product overlap rate, and continuous price wars, the profit margins of pharmaceutical machine companies are constantly being squeezed, which poses challenges to the internal management level of the company
.
However, there are generally deficiencies and shortcomings in the operation and management of pharmaceutical machine enterprises in China.
How to improve technological innovation capabilities, how to reduce cost waste, how to promote strategic layout.
.
.
Every aspect requires enterprises to carry out "lean management"
.
At present, lean management is regarded as an important internal management model by many domestic pharmaceutical machine companies
.
For example, some companies actively promote precise management, seek benefits from management, use management methods to solve development problems, promote the construction of management structures, processes and IT-supported management systems for headquarters functional departments, and build marketing systems, sales and service platforms, and R&D systems.
and R&D platform, manufacturing and supply chain platform, human resources platform, and financial platform, continuously improve management level, establish system and organizational competitiveness; there are also pharmaceutical machine companies actively researching and improving the level of automation, informatization and intelligence, and gradually through the implementation of modern management Achieve lean management and lean production
.
At the same time, based on the company's business practice, the company highlights the combination of standardized operations and flexible production management, and gradually replaces manual operations with intelligent equipment to improve product quality and production efficiency, thereby enhancing the competitiveness of the company
.
.
For example, some companies actively promote precise management, seek benefits from management, use management methods to solve development problems, promote the construction of management structures, processes and IT-supported management systems for headquarters functional departments, and build marketing systems, sales and service platforms, and R&D systems.
and R&D platform, manufacturing and supply chain platform, human resources platform, and financial platform, continuously improve management level, establish system and organizational competitiveness; there are also pharmaceutical machine companies actively researching and improving the level of automation, informatization and intelligence, and gradually through the implementation of modern management Achieve lean management and lean production
.
At the same time, based on the company's business practice, the company highlights the combination of standardized operations and flexible production management, and gradually replaces manual operations with intelligent equipment to improve product quality and production efficiency, thereby enhancing the competitiveness of the company
.
Third, attach importance to talent training, strengthen the construction of talent echelon, and explore and improve the value creation ability of employees
.
Talent is the cornerstone of the long-term development of an enterprise.
Pharmaceutical equipment is a complex and comprehensive application discipline.
Pharmaceutical machinery enterprises should pay more attention to the cultivation of professional and skilled personnel, and make efforts in the recruitment and retention of talents.
Only a stable talent team can support the enterprise.
More stable development brings continuous impetus to product innovation, thereby enhancing the market competitiveness of enterprises
.
.
Talent is the cornerstone of the long-term development of an enterprise.
Pharmaceutical equipment is a complex and comprehensive application discipline.
Pharmaceutical machinery enterprises should pay more attention to the cultivation of professional and skilled personnel, and make efforts in the recruitment and retention of talents.
Only a stable talent team can support the enterprise.
More stable development brings continuous impetus to product innovation, thereby enhancing the market competitiveness of enterprises
.
Original title: The domestic pharmaceutical equipment industry market competition is becoming increasingly fierce, how should enterprises respond?
